Patents Assigned to Alimentary Health Ltd.
  • Publication number: 20190264168
    Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.
    Type: Application
    Filed: December 3, 2018
    Publication date: August 29, 2019
    Applicants: University College Cork, National University of Ireland, Teagasc- The Agriculture and Food Development Authority, Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
  • Patent number: 10233433
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: March 19, 2019
    Assignees: Alimentary Health Ltd., The Procter & Gamble Company
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Patent number: 10144978
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: December 4, 2018
    Assignee: Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Publication number: 20180282825
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 4, 2018
    Applicant: Alimentary Health Ltd.
    Inventors: Liam O'MAHONY, Barry KIELY, John Francis CRYAN, Timothy DINAN, Eileen Frances MURPHY
  • Publication number: 20180202010
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: July 19, 2018
    Applicant: Alimentary Health Ltd
    Inventors: Liam O'MAHONY, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Patent number: 9259019
    Abstract: Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: February 16, 2016
    Assignees: Mars, Incorporated, Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely
  • Patent number: 8900568
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8877178
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 4, 2014
    Assignees: The Iams Company, Alimentary Health Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8840880
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: September 23, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8809035
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium globosum of the present invention are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: August 19, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Patent number: 8802158
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: August 12, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Publication number: 20130209429
    Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.
    Type: Application
    Filed: March 27, 2013
    Publication date: August 15, 2013
    Applicants: University College Cork, National University of Ireland, Cork, Alimentary Health Ltd., TEAGASC - The Agriculture and Food Development Authority
    Inventors: University College Cork, National University of Ireland, Cork, TEAGASC - The Agriculture and Food Development Authority, Alimentary Health Ltd.
  • Patent number: 8168170
    Abstract: Disclosed are compositions comprising an inner core and at least two surrounding layers. The compositions are suitable for use in humans and other mammals, particularly wherein a component of the inner core is susceptible to moisture. The compositions comprise an inner core comprising one or more components; an inner layer which surrounds the inner core, wherein the inner layer is selected from continuous coatings insoluble at a pH of about 3 or less, continuous coatings having a coating weight of from about 3 mg/cm2, and combinations thereof; and an outer layer which surrounds the inner layer, wherein the outer layer is hydrophobic.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: May 1, 2012
    Assignees: The Procter and Gamble Company, Alimentary Health Ltd.
    Inventor: Graham John Myatt
  • Publication number: 20100284979
    Abstract: The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria.
    Type: Application
    Filed: September 30, 2008
    Publication date: November 11, 2010
    Applicants: UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND, CORK, TEAGASC, The Agriculture and Food Development Authority, ALIMENTARY HEALTH LTD.
    Inventors: Liam O'Mahony, Fergus Shanahan, Eamonn Quigley, Paul Ross, Catherine Stanton
  • Publication number: 20080118473
    Abstract: Disclosed herein are methods for treating a respiratory condition in a mammal, such as a human. The methods employ use of a composition comprising a Bifidobacterium probiotic.
    Type: Application
    Filed: October 31, 2007
    Publication date: May 22, 2008
    Applicants: The Procter & Gamble Company, Alimentary Health Ltd.
    Inventors: Barry Pius Kiely, Liam Diarmuid O'Mahony, David Alexander Lawson
  • Publication number: 20040228837
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: March 26, 2004
    Publication date: November 18, 2004
    Applicant: The Procter & Gamble Company and Alimentary Health, Ltd.
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Publication number: 20040197304
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: April 1, 2003
    Publication date: October 7, 2004
    Applicant: The Procter & Gamble Company and Alimentary Health, Ltd.
    Inventors: Ker-Sang Chen, Fangyi Luo, Liam Diarmuid O'Mahony